![Vincent Liptak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vincent Liptak
General Counsel at
BLOSSOMHILL THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-07-30
Profile
Dr. Vincent Liptak is an Executive Vice President & General Counsel at Blossomhill Therapeutics, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-09 | 134,099 ( 0.44% ) | 2 M $ | 2026-07-30 |
Vincent Liptak active positions
| Companies | Position | Start |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | General Counsel | 2023-03-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Vincent Liptak
